269 related articles for article (PubMed ID: 14610218)
1. Kinetic study on the reactions of platinum drugs with glutathione.
Hagrman D; Goodisman J; Souid AK
J Pharmacol Exp Ther; 2004 Feb; 308(2):658-66. PubMed ID: 14610218
[TBL] [Abstract][Full Text] [Related]
2. Kinetic study on the reaction of cisplatin with metallothionein.
Hagrman D; Goodisman J; Dabrowiak JC; Souid AK
Drug Metab Dispos; 2003 Jul; 31(7):916-23. PubMed ID: 12814969
[TBL] [Abstract][Full Text] [Related]
3. Analysis of cytotoxicities of platinum compounds.
Goodisman J; Hagrman D; Tacka KA; Souid AK
Cancer Chemother Pharmacol; 2006 Jan; 57(2):257-67. PubMed ID: 16028101
[TBL] [Abstract][Full Text] [Related]
4. Interaction of oxaliplatin, cisplatin, and carboplatin with hemoglobin and the resulting release of a heme group.
Mandal R; Kalke R; Li XF
Chem Res Toxicol; 2004 Oct; 17(10):1391-7. PubMed ID: 15487901
[TBL] [Abstract][Full Text] [Related]
5. Reaction of polynuclear platinum antitumor compounds with reduced glutathione studied by multinuclear (1H, 1H-15N gradient heteronuclear single-quantum coherence, and 195Pt) NMR spectroscopy.
Oehlsen ME; Qu Y; Farrell N
Inorg Chem; 2003 Sep; 42(18):5498-506. PubMed ID: 12950196
[TBL] [Abstract][Full Text] [Related]
6. EXAFS and IR structural study of platinum-based anticancer drugs' degradation by diethyl dithiocarbamate.
Bouvet D; Michalowicz A; Crauste-Manciet S; Brossard D; Provost K
Inorg Chem; 2006 Apr; 45(8):3393-8. PubMed ID: 16602799
[TBL] [Abstract][Full Text] [Related]
7. Free radical-induced redox chemistry of platinum-containing anti-cancer drugs.
Swancutt KL; Mezyk SP; Kiddle JJ
Radiat Res; 2007 Oct; 168(4):423-7. PubMed ID: 17903044
[TBL] [Abstract][Full Text] [Related]
8. The kinetics and mechanisms of the reaction of Mesna with cisplatin, oxiplatin and carboplatin.
Oprea A; Bazzazi H; Kangarloo B; Wolff JE
Anticancer Res; 2001; 21(2A):1225-9. PubMed ID: 11396168
[TBL] [Abstract][Full Text] [Related]
9. Equilibrium, kinetic and HPLC study of the reactions between platinum(II) complexes and DNA constituents in the presence and absence of glutathione.
Bugarcić ZD; Soldatović T; Jelić R; Algueró B; Grandas A
Dalton Trans; 2004 Nov; (22):3869-77. PubMed ID: 15540131
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of reaction of L-methionine with carboplatin and oxaliplatin in different media: a comparison with cisplatin.
Heudi O; Mercier-Jobard S; Cailleux A; Allain P
Biopharm Drug Dispos; 1999 Mar; 20(2):107-16. PubMed ID: 10206326
[TBL] [Abstract][Full Text] [Related]
11. Kinetic study of the reaction of cisplatin with thiols.
Dabrowiak JC; Goodisman J; Souid AK
Drug Metab Dispos; 2002 Dec; 30(12):1378-84. PubMed ID: 12433807
[TBL] [Abstract][Full Text] [Related]
12. The chemical reactivity of BNP7787 and its metabolite mesna with the cytostatic agent cisplatin: comparison with the nucleophiles thiosulfate, DDTC, glutathione and its disulfide GSSG.
Verschraagen M; Kedde MA; Hausheer FH; Van Der Vijgh WJ
Cancer Chemother Pharmacol; 2003 Jun; 51(6):499-504. PubMed ID: 12715205
[TBL] [Abstract][Full Text] [Related]
13. Disulfide bond cleavage induced by a platinum(II) methionine complex.
Wei H; Wang X; Liu Q; Mei Y; Lu Y; Guo Z
Inorg Chem; 2005 Aug; 44(17):6077-81. PubMed ID: 16097828
[TBL] [Abstract][Full Text] [Related]
14. Oxaliplatin degradation in the presence of important biological sulphur-containing compounds and plasma ultrafiltrate.
Jerremalm E; Wallin I; Yachnin J; Ehrsson H
Eur J Pharm Sci; 2006 Jul; 28(4):278-83. PubMed ID: 16621479
[TBL] [Abstract][Full Text] [Related]
15. Thermodynamic and kinetic studies on reactions of Pt(II) complexes with biologically relevant nucleophiles.
Summa N; Schiessl W; Puchta R; van Eikema Hommes N; van Eldik R
Inorg Chem; 2006 Apr; 45(7):2948-59. PubMed ID: 16562950
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of the interactions of cisplatin and carboplatin with nucleotides using UV resonance Raman spectroscopy.
Benson RL; Gustafson TL
Biopolymers; 1993 Nov; 33(11):1631-41. PubMed ID: 8241424
[TBL] [Abstract][Full Text] [Related]
17. Quantitative measurement of the reduction of platinum(IV) complexes using X-ray absorption near-edge spectroscopy (XANES).
Hall MD; Daly HL; Zhang JZ; Zhang M; Alderden RA; Pursche D; Foran GJ; Hambley TW
Metallomics; 2012 Jun; 4(6):568-75. PubMed ID: 22569908
[TBL] [Abstract][Full Text] [Related]
18. New synthetic route to [bis-1,2-(aminomethyl)benzene]dichloroplatinum(II) complexes, screening for cytotoxic activity in cisplatin-sensitive and resistant human cancer cell lines, and reaction with glutathione.
Rinke K; Grünert R; Bednarski PJ
Pharmazie; 2001 Oct; 56(10):763-9. PubMed ID: 11683118
[TBL] [Abstract][Full Text] [Related]
19. EXAFS structural study of platinum-based anticancer drugs degradation in presence of sulfur nucleophilic species.
Provost K; Bouvet-Muller D; Crauste-Manciet S; Moscovici J; Olivi L; Vlaic G; Michalowicz A
Biochimie; 2009 Oct; 91(10):1301-6. PubMed ID: 19607872
[TBL] [Abstract][Full Text] [Related]
20. HPLC analysis of platinum cytostatics.
Brandsteterová E; Kiss F; Chovancová V; Reichelová V
Neoplasma; 1991; 38(4):415-24. PubMed ID: 1922573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
